Jagsonpal Pharmaceuticals Ltd
JAGSNPHARM
Company Profile
Business description
Jagsonpal Pharmaceuticals Ltd is a pharmaceutical company. It develops and manufactures active pharmaceutical ingredients and formulations like Capsule and Tablet. The company operates in the Gynaecology, Orthopaedics, Dermatology and Paediatric segments. Its brands comprise Lycored, Maintane, Doxypal DR, and others.
Contact
3rd Floor, Phase - IV, Udyog Vihar
Plot No. 412-415, Nimai Tower
GurugramHR122015
INDT: +91 1244406710
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
1,410
Stocks News & Analysis
stocks
Beaten down real estate share receives legal blow
Real estate share remains cheap despite losing airport legal battle.
stocks
OpenAI joins the mega-AI lab IPO race, but timing is uncertain
The ChatGPT maker joined Anthropic in filing a confidential S-1 with the SEC, teeing up a future IPO.
stocks
What happens if Tesla and SpaceX merge?
We see a solid business case for a merger, but not without hurdles, including Tesla shareholders’ concern about SpaceX’s valuation.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,006.10 | 29.10 | 0.32% |
| CAC 40 | 8,309.03 | 108.24 | 1.32% |
| DAX 40 | 24,455.24 | 245.53 | 1.01% |
| Dow JONES (US) | 50,862.66 | 13.91 | 0.03% |
| FTSE 100 | 10,412.92 | 109.04 | 1.06% |
| HKSE | 24,718.10 | 468.81 | 1.93% |
| NASDAQ | 25,624.46 | 185.20 | -0.72% |
| Nikkei 225 | 66,020.04 | 1,802.77 | 2.81% |
| NZX 50 Index | 13,393.87 | 191.71 | 1.45% |
| S&P 500 | 7,370.15 | 24.15 | -0.33% |
| S&P/ASX 200 | 8,804.00 | 30.50 | 0.35% |
| SSE Composite Index | 4,031.51 | 44.50 | 1.12% |